- Home
- Reports
- Medical Device
- Artificial Pancreas Device System Market
Artificial Pancreas Device System Market Research Report by Type (CTR, CTT), End-user (Hospitals, Medical Centers, and Others), and Region (North America, Europe, APAC, RoW)–Global Forecast to 2027
ID: MRFR/MED/5208-HCR | February 2021 | Region: Global | 100 pages
Market Snapshot
The demand for artificial pancreas devices has increased lately as the cases related to pancreatic ailments and failures have grown substantially. The market is set to attain revenues valued at USD 341.08 million while forging ahead at a CAGR of 21.10% in the upcoming forecast period between 2017 and 2023. The escalating number of cases being diagnosed with diabetes is the key factor in promoting the development of the market. The rising inflow of investment in the market is expected to improve the product quality, thus increasing the sales of the market. As patients these days are more or less aware of the treatment options, they are also increasingly involved in the selection of their treatment options in certain cases. This factor is anticipated to reflect positively in the expansion of the artificial pancreas devices market in the upcoming forecast period.
Report Overview
The market perspective offered by MRFR spans the entire market and gives in-depth coverage of the latest trends that are shaping the future of the artificial pancreas device system market. The report aptly captures the development of the market through current market trends, historical growth analysis, and revenue projections for a period ranging to 2023. The market also mentions CTR (Control to Range) Systems and CTT (Control to Target) Systems. The end user segments such as hospital and medical centers are also significantly emphasized upon, and a detailed analysis of the segments is also presented in the report. The market dynamics related to pricing and feasibility analysis is significantly along with macroeconomic indicators, and feasibility indicators provides a comprehensive overview of the market in the forecast period.
Report Coverage
The report on the artificial pancreas device system market consists of market dynamics, forecast, historical market trends, market value by region as well as by country-level analysis for each market segment, segmentation, market factor analysis and key player’s market share analysis that includes supply chain and Porter’s five forces analysis of the market.
Companies Covered
Medtronic Plc, Bigfoot Biomedical, Johnson & Johnson, Dexcom Inc., Cellnovo, Tandem Diabetes Care Inc., Pancreum Inc., TypeZero Technologies LLC, Beta Bionics, F. Hoffmann-La Roche Ltd, Inreda Diabetic B.V., Insulet Corp
Research Methodology
The progression of research while creating reports at Market Research Future includes highlights and facts that are essential to the expansion of markets. The research initiated by our analysts enhances the capability of our clients to outline their vision for growth better. The unification of primary and secondary research approaches in our reports divulges widespread information connected to new revenue pockets and developing markets globally. The report methodology also ensures strategy roadmaps that exhibit a distinct picture of the present trends as well as the trends that can affect the forthcoming development of the market. An intrinsic level of understanding connected to the value chain in a specific market additionally contributes to the value of the reports created by our analysts. Furthermore, the insights into markets, technologies, and industry sectors is positively achieved by the application of top-down and bottom-up approaches.
Segmental Analysis
The segmentation of the artificial pancreas device market has been carried out to better gauge the market.
By Type
- CTR (Control to Range) Systems
- CTT (Control To Target) Systems
By End User
- Hospitals
- Medical Centers
By Region
- North America
- South America
- Europe
- Asia-Pacific
- Middle East
- Africa
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Artifical Pancreas Device System (APDS) Market, by Type
6.1 Introduction
6.2 CTR (Control to Range) Systems
Market Estimates & Forecast by region, 2020-2027
Market Estimates & Forecast country, 2020-2027
6.3 CTT (Control to Target) Systems
Market Estimates & Forecast by region, 2020-2027
Market Estimates & Forecast country, 2020-2027
Chapter 7. Global Artifical Pancreas Device System (APDS) Market, by End User
7.1 Introduction
7.2 Hospitals
Market Estimates & Forecast by region, 2020-2027
Market Estimates & Forecast country, 2020-2027
7.3 Medical Centers
Market Estimates & Forecast by region, 2020-2027
Market Estimates & Forecast country, 2020-2027
7.4 Others
Chapter 8. Global Artifical Pancreas Device System (APDS) Market, by Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 U.S.
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 Italy
8.3.1.4 Spain
8.3.1.5 U.K.
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Republic of Korea
8.4.6 Rest of Asia Pacific
8.5 The Middle East & Africa
8.5.1 The Middle East
8.5.2 Africa
Chapter 9. Company Landscape
9.1 Introduction
9.2 Market Share Analysis
9.3 Key Development & Strategies
Chapter 10. Company Profiles
10.1 Medtronic plc
10.1.1 Company Overview
10.1.2 Product Overview
10.1.3 Financials Overview
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 Bigfoot Biomedical
10.2.1 Company Overview
10.2.2 Product Overview
10.2.3 Financial Overview
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 Johnson & Johnson
10.3.1 Company Overview
10.3.2 Product Overview
10.3.3 Financial Overview
10.3.4 Key Development
10.3.5 SWOT Analysis
10.4 Dexacom, Inc.
10.4.1 Company Overview
10.4.2 Technologys/Business Segment Overview
10.4.3 Financial Overview
10.4.4 Key Development
10.4.5 SWOT Analysis
10.5 CELLNOVO
10.5.1 Company Overview
10.5.2 Product Overview
10.5.3 Financial overview
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.6 Tandem Diabetes Care, Inc.
10.6.1 Company Overview
10.6.2 Product Overview
10.6.3 Financial Overview
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.7 Pancreum, Inc.
10.7.1 Overview
10.7.2 Product Overview
10.7.3 Financial Overview
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.8 TypeZero Technologies, LLC
10.8.1 Overview
10.8.2 Product/ Technology Overview
10.8.3 Financials
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.9 Beta Bionics
10.9.1 Overview
10.9.2 Product Overview
10.9.3 Financials
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.10 F. Hoffmann-La Roche Ltd
10.10.1 Overview
10.10.2 Product Overview
10.10.3 Financials
10.10.4 Key Developments
10.10.5 SWOT Analysis
10.11 Inreda Diabetic B.V.
10.11.1 Overview
10.11.2 Product Overview
10.11.3 Financials
10.11.4 Key Developments
10.11.5 SWOT Analysis
10.12 Insulet Corp
10.12.1 Overview
10.12.2 Product Overview
10.12.3 Financials
10.12.4 Key Developments
10.12.5 SWOT Analysis
10.13 Others
Chapter 11 MRFR Conclusion
11.1 Key Findings
11.1.1 From CEO’s View Point
11.1.2 Unmet Needs of the Market
11.2 Key Companies to Watch
11.3 Prediction of the Artifical Pancreas Device System (APDS) Industry
Chapter 12 Appendix
LIST OF TABLES
Table 1 Global Artifical Pancreas Device System (APDS) Market Synopsis, 2020-2027(USD Million)
Table 2 Global Artifical Pancreas Device System (APDS) Market Estimates and Forecast, 2018– 2023, (USD Million)
Table 3 Global Artifical Pancreas Device System (APDS) Market, by Region, 2020-2027, (USD Million)
Table 4 Global Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)
Table 5 Global Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)
Table 6 Global Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)
Table 7 North America Global Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)
Table 8 North America Global Artifical Pancreas Device System (APDS) Market, by End User, 2020-2027, (USD Million)
Table 9 US Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)
Table 10 US Artifical Pancreas Device System (APDS) Market, by Technology, 2020-2027, (USD Million)
Table 11 US Artifical Pancreas Device System (APDS) Market, by End User, 2020-2027, (USD Million)
Table 12 Canada Artifical Pancreas Device System (APDS) Market,by Type, 2020-2027, (USD Million)
Table 13 Canada Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)
Table 14 South America Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)
Table 15 South America Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)
Table 16 Europe Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)
Table 17 Europe Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)
Table 18 Western Europe Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)
Table 19 Western Europe Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)
Table 20 Eastern Europe Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)
Table 21 Eastern Europe Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)
Table 22 Asia Pacific Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)
Table 23 Asia Pacific Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)
Table 24 Middle East & Africa Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)
Table 25 Middle East & Africa Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Artifical Pancreas Device System (APDS) Market
Figure 3 Segmentation Market Dynamics for Global Artifical Pancreas Device System (APDS) Market
Figure 4 Global Artifical Pancreas Device System (APDS) Market Share, by Type 2020
Figure 5 Global Artifical Pancreas Device System (APDS) Market Share, by End-User, 2020
Figure 6 Global Artifical Pancreas Device System (APDS) Market Share, by Region, 2020
Figure 7 North America Artifical Pancreas Device System (APDS) Market Share, by Country, 2020
Figure 8 Europe Artifical Pancreas Device System (APDS) Market Share, by Country, 2020
Figure 9 Asia Pacific Artifical Pancreas Device System (APDS) Market Share, by Country, 2020
Figure 10 Middle East & Africa Artifical Pancreas Device System (APDS) Market Share, by Country, 2020
Figure 11 Global Artifical Pancreas Device System (APDS) Market: Company Share Analysis, 2020 (%)
Figure 12 Medtronic plc: Key Financials
Figure 13 Medtronic plc: Segmental Revenue
Figure 14 Medtronic plc: Geographical Revenue
Figure 15 Bigfoot Biomedical: Key Financials
Figure 16 Bigfoot Biomedical: Segmental Revenue
Figure 17 Bigfoot Biomedical: Geographical Revenue
Figure 18 Johnson & Johnson::Key Financials
Figure 19 Johnson & Johnson: Segmental Revenue
Figure 20 Johnson & Johnson: Geographical Revenue
Figure 21 Dexacom, Inc.: Key Financials
Figure 22 Dexacom, Inc.: Segmental Revenue
Figure 23 Dexacom, Inc.: Geographical Revenue
Figure 24 CELLNOVO:Key Financials
Figure 25 CELLNOVO: Segmental Revenue
Figure 26 CELLNOVO. Geographical Revenue
Figure 27 Tandem Diabetes Care, Inc.: Key Financials
Figure 28 Tandem Diabetes Care, Inc.: Segmental Revenue
Figure 29 Tandem Diabetes Care, Inc.: Geographical Revenue
Figure 30 Pancreum, Inc.: Key Financials
Figure 31 Pancreum, Inc.: Segmental Revenue
Figure 32 Pancreum, Inc.: Geographical Revenue
Figure 33 TypeZero Technologies, LLC: Key Financials
Figure 34 TypeZero Technologies, LLC: Segmental Revenue
Figure 35 TypeZero Technologies, LLC: Geographical Revenue
Figure 36 Beta Bionics: Key Financials
Figure 37 Beta Bionics: Segmental Revenue
Figure 38 Beta Bionics: Geographical Revenue
Figure 39 F. Hoffmann-La Roche Ltd: Key Financials
Figure 40 F. Hoffmann-La Roche Ltd: Segmental Revenue
Figure 41 F. Hoffmann-La Roche Ltd: Geographical Revenue
Figure 42 Inreda Diabetic B.V.: Key Financials
Figure 43 Inreda Diabetic B.V.: Segmental Revenue
Figure 44 Inreda Diabetic B.V.: Geographical Revenue
Figure 45 Insulet Corp: Key Financials
Figure 46 Insulet Corp: Segmental Revenue
Figure 47 Insulet Corp: Geographical Revenue
